- My Alerts
- Go Ad-Free
-
My Account
In App
BSE Live
Feb 26, 09:25Prev. Close
4138.75
Open Price
4015.05
Bid Price (Qty.)
3987.70 (2)
Offer Price (Qty.)
3994.90 (5)
NSE Live
Feb 26, 09:25Prev. Close
4134.70
Open Price
4045.00
Bid Price (Qty.)
3991.00 (10)
Offer Price (Qty.)
3993.10 (4)
| Cash Flow of Sanofi India (in Rs. Cr.) | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 444.70 | 562.60 | 845.80 | 864.30 | 1,257.60 | |
| Net CashFlow From Operating Activities | 438.30 | 461.70 | 230.80 | 398.70 | 558.80 | |
| Net Cash Used In Investing Activities | -11.30 | -19.20 | 35.50 | 650.90 | 630.80 | |
| Net Cash Used From Financing Activities | -447.90 | -392.40 | -878.30 | -1,582.70 | -849.00 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | -159.20 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -20.90 | -109.10 | -612.00 | -533.10 | 340.60 | |
| Cash And Cash Equivalents Begin of Year | 283.80 | 392.90 | 1,004.90 | 1,538.00 | 1,197.40 | |
| Cash And Cash Equivalents End Of Year | 262.90 | 283.80 | 392.90 | 1,004.90 | 1,538.00 |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y
